Lawrence D. Mayer - Concepedia

Author

Lawrence D. Mayer

University of British Columbia

Also Known As

Daniel J Cameron, L D Mayer, LAWRENCE D. MAYER, Lawrence D Mayer, Lawrence D. Mayer, Lawrence Mayer

168

Publications

10.4K

Citations

H-Index

107

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Celator Pharmaceuticals (Canada)University of Minnesota, Duluth Inimex Pharmaceuticals (Canada)

About

Lawrence D. Mayer is an author at University of British Columbia specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	56	4.8K
2	Natural Sciences	9	9	697
3	Engineering	7	7	514
4	Health Sciences	5	5	147
5	Public Health	1	1	50

Lawrence D. Mayer

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
The Liposomal Formulation of Doxorubicin Sheela A. Abraham, Dawn Waterhouse, Lawrence D. Mayer, Methods in enzymology on CD-ROM/Methods in enzymology Lipid PreparationMedicinal ChemistryMedicineLiposomal FormulationLipid Chemistry	2005	413
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Lawrence D. Mayer, Linda C.L. Tai, Dicken S. C. Ko, PubMed Lipid AnalysisProteinlipid InteractionLipid PreparationBiochemistryDoxorubicin Inside Liposomes	1989	355
In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy Paul Tardi, Sharon A. Johnstone, Natashia Harasym, Leukemia Research Daunorubicin RatiosPharmacologyVivo MaintenancePharmacotherapyDrug Development	2008	349
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice Lawrence D. Mayer, Troy O. Harasym, Paul Tardi, Molecular Cancer Therapeutics	2006	324
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz, Journal of Clinical Oncology	2011	299
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey Thomas D. Madden, Paul Richard Harrigan, Linda C.L. Tai, Chemistry and Physics of Lipids Proteinlipid InteractionPharmaceutical ScienceMedicineMembrane TransportProton Gradient	1990	252
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients Lawrence D. Mayer, Linda C.L. Tai, Marcel B. Bally, Biochimica et Biophysica Acta (BBA) - Biomembranes Lipid PreparationProteinlipid InteractionBiochemistryLiposomal SystemsLipid Movement	1990	243
Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Yanping Hu, Gabriele Cherton-Horvat, Visia Dragowska, PubMed Tumor BiologyDrug TargetingOncogenic AgentChemotherapeutic ActivityMedicine	2003	220
Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors Gerald Batist, Karen A. Gelmon, Kim N., Clinical Cancer Research	2009	210
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential Lawrence D. Mayer, Marcel B. Bally, Michael J. Hope, Biochimica et Biophysica Acta (BBA) - Biomembranes NanomedicineMembrane PotentialMembrane FormationAntineoplastic AgentsMembrane Transport	1985	192

Page 1